ContraFect Corp Stock Nasdaq
Equities
US2123262014
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
May. 03 | North American Morning Briefing : Apple, Amgen -2- | DJ |
Apr. 26 | North American Morning Briefing : Tech Still in -2- | DJ |
Financials (USD)
Sales 2021 | - | Sales 2022 | - | Capitalization | 4.19M |
---|---|---|---|---|---|
Net income 2021 | -20M | Net income 2022 | -65M | EV / Sales 2021 | - |
Net cash position 2021 | 51.02M | Net cash position 2022 | 10.8M | EV / Sales 2022 | - |
P/E ratio 2021 |
-4.77
x | P/E ratio 2022 |
-0.06
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 99.98% |
1st Jan change | Capi. | |
---|---|---|
+33.63% | 50.93B | |
-0.09% | 42.12B | |
+49.62% | 42.05B | |
-4.96% | 29.18B | |
+11.18% | 26.02B | |
-21.95% | 18.9B | |
+8.61% | 13.21B | |
+24.73% | 12.17B | |
+28.31% | 12.16B |